Homology Medicines (BATS:FIXX) CEO Jodie Pope Morrison Sells 9,845 Shares

Homology Medicines, Inc. (BATS:FIXX) CEO Jodie Pope Morrison sold 9,845 shares of the business’s stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $16.56, for a total transaction of $163,033.20. Following the sale, the chief executive officer owned 343,259 shares of the company’s stock, valued at approximately $5,684,369.04. This represents a 2.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Homology Medicines Stock Down 1.2%

Shares of FIXX stock opened at $12.73 on Friday. Homology Medicines, Inc. has a 52 week low of $12.02 and a 52 week high of $14.30.

Homology Medicines, Inc was a clinical-stage biotechnology company focused on developing genetic medicines for patients with rare diseases. The company sought to use its proprietary human-derived adeno-associated virus vectors, known as AAVHSCs, to deliver gene therapies in vivo and address the underlying causes of inherited disorders.

Its development programs included HMI-103, an investigational gene therapy for phenylketonuria, as well as earlier programs targeting other rare diseases.